I had already asked a question about the phenotype of residual disease (visceral lesions of the "tuberous sclerosis" or lymphangioleiomyomatosis) after treatment with rapamycin or analogues. There was no response. I would like to insist and ask if you know if anyone has done some immunophenotypic characterization of cell lines (associated with these diseases) before and after addition of rapamycin or analogues.
https://www.researchgate.net/post/What_is_the_immunophenotype_of_angiomyolipomas_residual_disease_after_treatment_with_mTOR_inhibitors?_tpcectx=profile_questions
Dear Maurizio, I am not the correct Vincenzo Pavone, I am a social scientist. The person you are looking for is a Professor working in the University of Naples. Best of Luck
Dear Ying I have attached two papers on the subject
Article PEComas: The past, the present and the future
Article Cathepsin K expression in the spectrum of perivascular epith...
- Badges
- Science topic
- Similar topics
- Medicine
- Oncology
- Cancer Research